Product Information
GILENYA 0.5 MG CAPSULE is a brand product labeled by Novartis Pharmaceuticals Corporation, priced at $414.7110 per EA under NDC 00078060715. Its NADAC has been published 566 times since Mar 11, 2015.
FDA first approved this application on Sep 21, 2010. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
.5 mg/1
Manufacturer
Novartis Pharmaceuticals CorporationNDC
00078060715
Classification
Brand
Dosage Form
CAPSULE
Route
ORAL
Effective Date
1/7/2026
Active Ingredients
FINGOLIMOD HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA022527FDA Approved
9/21/2010
TE Code
AB
On Market Since
9/21/2010
Pharmacological Classes
Price Statistics
The NADAC for GILENYA 0.5 MG CAPSULE has been published 566 times since Mar 11, 2015, and over the history we have for it it has risen 136.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $414.7110 per EA |
|---|---|
| All-time high | $414.7110 (Mar 11, 2026) |
| All-time low | $175.4372 (Mar 11, 2015) |
| 52-week high | $414.7110 |
| 52-week low | $377.3531 |
| Median price | $280.8327 |
| Average price | $286.0132 |
| Largest weekly change | +9.9% (Jan 14, 2026) |
| Weeks tracked | 566 |
| Tracking since | Mar 11, 2015 |
1W
N/A
1M
N/A
3M
N/A
6M
0.0%
1Y
+9.9%
3Y
+22.7%
5Y
+40.6%
All
+136.4%
Last surveyed Mar 11, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 99% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of GILENYA 0.5 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for GILENYA 0.5 MG CAPSULE, manufactured by Novartis Pharmaceuticals Corporation, is $414.7110 per EA (NDC 00078060715), effective Mar 11, 2026.
How has the price of GILENYA 0.5 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for GILENYA 0.5 MG CAPSULE has risen 136.4%. It has been tracked across 566 weekly CMS publications since Mar 11, 2015.
What are the highest and lowest recorded NADAC prices for GILENYA 0.5 MG CAPSULE?
Since Mar 11, 2015, the NADAC for GILENYA 0.5 MG CAPSULE has ranged from a low of $175.4372 (Mar 11, 2015) to a high of $414.7110 (Mar 11, 2026), with a median of $280.8327 per EA.
Are there cheaper alternatives to GILENYA 0.5 MG CAPSULE?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, FINGOLIMOD 0.5 MG CAPSULE, is $2.0973 per EA — about 99% below GILENYA 0.5 MG CAPSULE.
Who manufactures GILENYA 0.5 MG CAPSULE?
GILENYA 0.5 MG CAPSULE (NDC 00078060715) is labeled by Novartis Pharmaceuticals Corporation, and CMS classifies it as a brand product.